Mpox

11 registered clinical trials studyying Mpox — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MB NCT07499739	Institute of Tropical Medicine, Belgium	Phase 4
Not Yet Recruiting	Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) NCT07093489	International Vaccine Institute	—
Active Not Recruiting	Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC NCT06844500	Jean-Pierre Van geertruyden	Phase 3
Recruiting	Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks NCT06887556	University of Birmingham	N/A
Recruiting	Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX) NCT05784038	Hospital Israelita Albert Einstein	—
Completed	A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared NCT05995275	ModernaTX, Inc.	Phase 1 / Phase 2
Completed	Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts NCT06136117	Institute of Tropical Medicine, Belgium	—
Recruiting	Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease NCT05597735	ANRS, Emerging Infectious Diseases	Phase 3
Enrolling By Invitation	New York City Observational Study of Mpox Immunity NCT05654883	NYU Langone Health	—
Completed	Break-through Infection Following Mpox vaccinatIon NCT05522296	Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia	—
Terminated	Study of Tecovirimat for Human Mpox Virus NCT05534984	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3